BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

799 related articles for article (PubMed ID: 32268905)

  • 41. Prediction of pre-eclampsia: review of reviews.
    Townsend R; Khalil A; Premakumar Y; Allotey J; Snell KIE; Chan C; Chappell LC; Hooper R; Green M; Mol BW; Thilaganathan B; Thangaratinam S;
    Ultrasound Obstet Gynecol; 2019 Jul; 54(1):16-27. PubMed ID: 30267475
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Screening for small for gestational age using third-trimester ultrasound markers: protocol for a systematic review and meta-analysis of screening test accuracy.
    Gasse C; Paquette K; Demers S; Roberge S; Bujold E; Boutin A
    Syst Rev; 2018 Dec; 7(1):219. PubMed ID: 30509320
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of marginal cord insertion on perinatal outcomes: a systematic review and meta-analysis.
    Siargkas A; Tsakiridis I; Pachi C; Mamopoulos A; Athanasiadis A; Dagklis T
    Am J Obstet Gynecol MFM; 2023 Apr; 5(4):100876. PubMed ID: 36708965
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prospective evaluation of first-trimester screening strategy for preterm pre-eclampsia and its clinical applicability in China.
    Hu J; Gao J; Liu J; Meng H; Hao N; Song Y; Ma L; Luo W; Sun J; Gao W; Meng W; Sun Y
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):529-539. PubMed ID: 33817865
    [TBL] [Abstract][Full Text] [Related]  

  • 45. PARROT Ireland: Placental growth factor in Assessment of women with suspected pre-eclampsia to reduce maternal morbidity: a Stepped Wedge Cluster Randomised Control Trial Research Study Protocol.
    Hayes-Ryan D; Hemming K; Breathnach F; Cotter A; Devane D; Hunter A; McAuliffe FM; Morrison JJ; Murphy DJ; Khashan A; McElroy B; Murphy A; Dempsey E; O'Donoghue K; Kenny LC
    BMJ Open; 2019 Mar; 9(2):e023562. PubMed ID: 30826791
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduced fetal movement intervention Trial-2 (ReMIT-2): protocol for a pilot randomised controlled trial of standard care informed by the result of a placental growth factor (PlGF) blood test versus standard care alone in women presenting with reduced fetal movement at or after 36
    Armstrong-Buisseret L; Mitchell E; Hepburn T; Duley L; Thornton JG; Roberts TE; Storey C; Smyth R; Heazell AEP
    Trials; 2018 Oct; 19(1):531. PubMed ID: 30285835
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maternal vascular malformation in the placenta is an indicator for fetal growth restriction irrespective of neonatal birthweight.
    Hendrix MLE; Bons JAP; Alers NO; Severens-Rijvers CAH; Spaanderman MEA; Al-Nasiry S
    Placenta; 2019 Nov; 87():8-15. PubMed ID: 31520871
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Calcium supplementation commencing before or early in pregnancy, or food fortification with calcium, for preventing hypertensive disorders of pregnancy.
    Hofmeyr GJ; Manyame S
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011192. PubMed ID: 28949421
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Aspirin for preventing adverse outcomes in low risk nulliparous women with singleton pregnancies: A systematic review and meta-analysis.
    Man R; Hodgetts Morton V; Devani P; Morris RK
    Eur J Obstet Gynecol Reprod Biol; 2021 Jul; 262():105-112. PubMed ID: 34010722
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Does low-dose aspirin initiated before 11 weeks' gestation reduce the rate of preeclampsia?
    Chaemsaithong P; Cuenca-Gomez D; Plana MN; Gil MM; Poon LC
    Am J Obstet Gynecol; 2020 May; 222(5):437-450. PubMed ID: 31494125
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biomarkers of impaired placentation at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
    Ciobanou A; Jabak S; De Castro H; Frei L; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Jul; 54(1):79-86. PubMed ID: 31100188
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Placental growth factor as an indicator of fetal growth restriction in late-onset small-for-gestational age pregnancies.
    Anderson N; De Laat M; Benton S; von Dadelszen P; McCowan L
    Aust N Z J Obstet Gynaecol; 2019 Feb; 59(1):89-95. PubMed ID: 29851029
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Placental growth factor testing at 19-23 weeks of gestation as a guide to subsequent care in pregnancy: A prospective observational study.
    Magee LA; Syngelaki A; Akolekar R; von Dadelszen P; Nicolaides KH
    BJOG; 2024 May; 131(6):803-810. PubMed ID: 37873570
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of encouraging awareness of reduced fetal movement and subsequent clinical management on pregnancy outcome: a systematic review and meta-analysis.
    Hayes DJL; Dumville JC; Walsh T; Higgins LE; Fisher M; Akselsson A; Whitworth M; Heazell AEP
    Am J Obstet Gynecol MFM; 2023 Mar; 5(3):100821. PubMed ID: 36481411
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pregnancy and neonatal outcomes of COVID-19: The PAN-COVID study.
    Mullins E; Perry A; Banerjee J; Townson J; Grozeva D; Milton R; Kirby N; Playle R; Bourne T; Lees C;
    Eur J Obstet Gynecol Reprod Biol; 2022 Sep; 276():161-167. PubMed ID: 35914420
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A placenta clinic approach to the diagnosis and management of fetal growth restriction.
    Kingdom JC; Audette MC; Hobson SR; Windrim RC; Morgen E
    Am J Obstet Gynecol; 2018 Feb; 218(2S):S803-S817. PubMed ID: 29254754
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pregnancy outcome of confined placental mosaicism: meta-analysis of cohort studies.
    Spinillo SL; Farina A; Sotiriadis A; Pozzoni M; Giglio S; Papale M; Candiani M; Cavoretto PI
    Am J Obstet Gynecol; 2022 Nov; 227(5):714-727.e1. PubMed ID: 35934121
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adverse maternal and neonatal outcomes among women with preeclampsia with severe features <34 weeks gestation with versus without comorbidity.
    Venkatesh KK; Strauss RA; Westreich DJ; Thorp JM; Stamilio DM; Grantz KL
    Pregnancy Hypertens; 2020 Apr; 20():75-82. PubMed ID: 32193149
    [TBL] [Abstract][Full Text] [Related]  

  • 59. First-Trimester Screening Program for the Risk of Pre-eclampsia Using a Multiple-Marker Algorithm: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2023; 22(5):1-118. PubMed ID: 37772268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prediction of fetal growth restriction using estimated fetal weight vs a combined screening model in the third trimester.
    Miranda J; Rodriguez-Lopez M; Triunfo S; Sairanen M; Kouru H; Parra-Saavedra M; Crovetto F; Figueras F; Crispi F; Gratacós E
    Ultrasound Obstet Gynecol; 2017 Nov; 50(5):603-611. PubMed ID: 28004439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.